
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Epidemiology Biomarkers & Prevention, Vol 4, Issue 1 69-77, Copyright © 1995 by American Association for Cancer Research
ARTICLES |
FJ van Schooten, FJ Jongeneelen, MJ Hillebrand, FE van Leeuwen, AJ de Looff, AP Dijkmans, JG van Rooij, L den Engelse and E Kriek
Department of Health Risk Analysis and Toxicology, University of Limburg, Maastricht, Netherlands.
We examined a group of 105 workers from a primary aluminum plant for the presence of polycyclic aromatic hydrocarbon (PAH)-DNA adducts in their WBC and 1-hydroxypyrene in their urine. Workers were recruited from five job categories with different PAH exposure: the anode factory; the bake oven; and the electrolysis and the pot-relining departments. Unexposed workers from the foundry department served as the control group. The exposure to PAH was measured by personal monitoring, and the average PAH concentrations in the work atmosphere ranged from 0.4 micrograms/m3 in the foundry to 150 micrograms/m3 in the pot-relining department. The average exposure to benzo(a)pyrene was under the Swedish exposure limit of 5 micrograms/m3. The internal dose of pyrene was measured utilizing the 1-hydroxypyrene concentration in pre- and postshift urine samples. Higher exposure to PAH in the work atmosphere was associated with increased concentrations of 1-hydroxypyrene in the urine. The average increase in concentration of 1-hydroxypyrene ranged from 0.2 mumol/mol creatinine in the control group to 5.9 mumol/mol creatinine in the pot-relining department; an accumulation of 1-hydroxypyrene over a 5-day working period was observed. A good correlation was found between PAH exposure and the concentration of 1-hydroxypyrene in the urine on a group level (rs = 0.90; P = 0.02). PAH-DNA adducts were determined by 32P-postlabeling analysis (nuclease P1 enrichment procedure).(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
E. Gyorffy, L. Anna, K. Kovacs, P. Rudnai, and B. Schoket Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts Mutagenesis, January 1, 2008; 23(1): 1 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Castano-Vinyals, A D'Errico, N Malats, and M Kogevinas Biomarkers of exposure to polycyclic aromatic hydrocarbons from environmental air pollution Occup. Environ. Med., April 1, 2004; 61(4): e12 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
D F Merlo, S Garattini, U Gelatti, C Simonati, L Covolo, M Ceppi, and F Donato A mortality cohort study among workers in a graphite electrode production plant in Italy Occup. Environ. Med., February 1, 2004; 61(2): e9 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Sim and G Benke World at work: Hazards and controls in aluminium potrooms Occup. Environ. Med., December 1, 2003; 60(12): 989 - 992. [Full Text] [PDF] |
||||
![]() |
P. V. Nerurkar, L. Okinaka, C. Aoki, A. Seifried, A. Lum-Jones, L. R. Wilkens, and L. Le Marchand CYP1A1, GSTM1, and GSTP1 Genetic Polymorphisms and Urinary 1-Hydroxypyrene Excretion in Non-Occupationally Exposed Individuals Cancer Epidemiol. Biomarkers Prev., October 1, 2000; 9(10): 1119 - 1122. [Abstract] [Full Text] |
||||
![]() |
M. Rojas, I. Cascorbi, K. Alexandrov, E. Kriek, G. Auburtin, L. Mayer, A. Kopp-Schneider, I. Roots, and H. Bartsch Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism Carcinogenesis, January 1, 2000; 21(1): 35 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W.L. Godschalk, E. J.C. Moonen, P. A.E.L. Schilderman, W. M.R. Broekmans, J. C.S. Kleinjans, and F. J. Van Schooten Exposure-route-dependent DNA adduct formation by polycyclic aromatic hydrocarbons Carcinogenesis, January 1, 2000; 21(1): 87 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Santella Immunological Methods for Detection of Carcinogen-DNA Damage in Humans Cancer Epidemiol. Biomarkers Prev., September 1, 1999; 8(9): 733 - 739. [Full Text] |
||||
![]() |
R. Pastorelli, M. Guanci, J. Restano, A. Berri, G. Micoli, C. Minoia, D. Alcini, P. Carrer, E. Negri, C. La Vecchia, et al. Seasonal Effect on Airborne Pyrene, Urinary 1-Hydroxypyrene, and Benzo(a)pyrene Diol Epoxide-Hemoglobin Adducts in the General Population Cancer Epidemiol. Biomarkers Prev., June 1, 1999; 8(6): 561 - 565. [Abstract] [Full Text] |
||||
![]() |
J P Arnould, A Pfohl-Leszkowicz, V Bach, J P Libert, and J Belegaud Biological monitoring exposure of workers from plant producing carbon electrodes: quantification of benzo[a]pyrene DNA adducts in leukocytes, by a 32P-postlabelling method and an immunoassay Human and Experimental Toxicology, May 1, 1999; 18(5): 314 - 321. [Abstract] [PDF] |
||||
![]() |
S. Pavanello, D. Favretto, F. Brugnone, G. Mastrangelo, G. D. Pra, and E. Clonfero HPLC/fluorescence determination of anti-BPDE–DNA adducts in mononuclear white blood cells from PAH-exposed humans Carcinogenesis, March 1, 1999; 20(3): 431 - 435. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |